US2019093149A1PendingUtilityA1
Assays for detecting multiple tick-borne pathogens
Est. expirySep 27, 2037(~11.1 yrs left)· nominal 20-yr term from priority
C12Q 1/689C12Q 1/6806C12Q 2600/16C12Q 1/686C12Q 2600/166C12Q 2600/112
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Kits, methods, and material for use in detecting tick-borne microorganism(s) are provided herein. One is able to detect DNA from several different species of microorganisms from samples (bodily fluid, tissue, etc.) from ticks and/or mammals to determine if one or more of the microorganisms has infected the tick and/or mammal. The assay uses PCR techniques with a multiple primers and probes. The microorganisms can be in the Borrelial Layer, the Rickettsiales Layer, and/or the Babesial Layer.
Claims
exact text as granted — not AI-modifiedWe, the inventors, claim:
1 . A kit for detecting Borrelia spp., Rickettsia -like bacteria, or Babesia spp. in a sample comprising at least one primer set for detecting said Borrelia spp., Rickettsia -like bacteria, or Babesia spp., an amplification control DNA, instructions for using said at least one primer set and said amplification control plasmid, optionally PCR reagents, and optionally reagents for isolating DNA from a sample.
2 . The kit of claim 1 , wherein said at least one primer set for said Borrelia spp. is selected from the primer sets of:
(i) SEQ ID NOs: 1 and 2, (ii) SEQ ID NOs: 5 and 7, (iii) SEQ ID NOs: 6 and 7, (iv) SEQ ID NOs: 11 and 13, (v) SEQ ID NOs: 12 and 13, and (vi) SEQ ID NOs: 17 and 18.
3 . The kit of claim 2 , further comprising at least one probe that contains a DNA sequence that present within the amplicon generated by each of said primer sets.
4 . The kit of claim 3 , wherein said at least one probe comprises SEQ ID NOs: 3, 8, 14, or 19.
5 . The kit of claim 1 , wherein said at least one primer set for said Rickettsia -like bacteria is selected from the primer sets of:
(vii) SEQ ID NOs: 21 and 22, (viii) SEQ ID NOs: 25 and 26, (ix) SEQ ID NOs: 29 and 30, (x) SEQ ID NOs: 33 and 34, and (xi) SEQ ID NOs: 36 and 34.
6 . The kit of claim 5 , further comprising at least one probe that contains a DNA sequence that present within the amplicon generated by each of said primer sets.
7 . The kit of claim 6 , wherein said at least one probe comprises SEQ ID NOs: 23, 27, or 31.
8 . The kit of claim 1 , wherein said at least one primer set for said Babesia spp. is selected from the primer sets of:
(xii) SEQ ID NOs: 38 and 39, and (xiii) SEQ ID NOs: 77 and 39.
9 . The kit of claim 8 , further comprising at least one probe that contains a DNA sequence that present within the amplicon generated by each of said primer sets.
10 . The kit of claim 9 , wherein said at least one probe comprises SEQ ID NO: 40.
11 . The kit of claim 1 ; wherein said kit comprises said primer sets:
(i) SEQ ID NOs: 1 and 2, (ii) SEQ ID NOs: 5 and 7, (iii) SEQ ID NOs: 6 and 7, (iv) SEQ ID NOs: 11 and 13, (v) SEQ ID NOs: 12 and 13, (vi) SEQ ID NOs: 17 and 18, (vii) SEQ ID NOs: 21 and 22, (viii) SEQ ID NOs: 25 and 26, (ix) SEQ ID NOs: 29 and 30, (x) SEQ ID NOs: 33 and 34, (xi) SEQ ID NOs: 36 and 34, (xii) SEQ ID NOs: 38 and 39, and (xiii) SEQ ID NOs: 77 and 39.
12 . The kit of claim 11 , wherein said Borrelia spp. is selected from the group consisting of Borrelia burgdorferi, B. hermsii, B. turicatae , and B. parkeri ; wherein said Rickettsia -like bacteria is selected from the group consisting of Ehrlichia canis, E. chaffeensis, E. ewingii, Anaplasma phagocytophilum , and Rickettsia rickettsii ; and wherein said Babesia spp. is selected from the group consisting of Babesia canis vogeli, B. gibsoni, B. canis canis, B. canis rossi, B. caballi, B. odocoilei, B. divergens , and B. bigemina.
13 . The kit of claim 11 , wherein said kit further comprises at least one Borrelia spp. probe, at least one Rickettsia -like bacteria probe, and at least one Babesia spp. probe; wherein said at least one Borrelia spp. probe comprises at least one of SEQ ID NOs: 3, 8, 14, and 19; wherein said at least one Rickettsia -like bacteria probe comprises at least one of SEQ ID NOs: 23, 27, and 31; and wherein said at least Babesia spp. probe comprises SEQ ID NO: 40.
14 . The kit of claim 11 , wherein said primer sets further comprise
(xiv) SEQ ID NOs: 46 and 47, (xv) SEQ ID NOs: 49 and 50, (xvi) SEQ ID NOs: 52 and 53, (xvii) SEQ ID NOs: 56 and 57, (xviii) SEQ ID NOs: 60 and 61, (xix) SEQ ID NOs: 64 and 65; and wherein said Borrelia spp. is selected from the group consisting of Borrelia burgdorferi, B. hermsii, B. turicatae , and B. parkeri ; wherein said Rickettsia -like bacteria is selected from the group consisting of Ehrlichia canis, E. chaffeensis, E. ewingii, Anaplasma phagocytophilum , and Rickettsia rickettsii ; and wherein said Babesia spp. is selected from the group consisting of Babesia canis vogeli, B. gibsoni, B. canis canis, B. canis rossi, B. caballi, B. odocoilei, B. divergens, B. bigemina , and B. conradae.
15 . The kit of claim 14 , wherein said kit further comprises at least one Borrelia spp. probe, at least one Rickettsia -like bacteria probe, and at least one Babesia spp. probe; wherein said at least one Borrelia spp. probe comprises at least one of SEQ ID NOs: 3, 8, 14, and 19; wherein said at least one Rickettsia -like bacteria probe comprises at least one of SEQ ID NOs: 23, 27, and 31; and wherein said at least Babesia spp. probe comprises at least one of SEQ ID NOs: 40, 54, 58, 62, and 66.
16 . The kit of claim 1 , wherein said amplification control plasmid comprises SEQ ID NO: 68.
17 . The kit of claim 1 , wherein when said sample is obtained from a canine, said amplification control plasmid comprises SEQ ID NO: 45, and said kit further comprises canine specific primer set of SEQ ID NOs: 42 and 43 and a canine specific probe comprising SEQ ID NO: 44.
18 . The kit of claim 1 , wherein said Borrelia spp. is B. burgdorferi ; wherein said Rickettsia -like bacteria is E. canis, E. chaffeensis , and A. phagocytophilum; wherein said primer set for detecting said B. burgdorferi comprises at least one of
(a)(i) SEQ ID NOs: 69 and 70 and (a)(ii) SEQ ID NOs: 1 and 2;
wherein said primer set for detecting E. canis comprises at least one of
(b)(i) SEQ ID NOs: 71 and 72 and (b)(ii) SEQ ID NOs: 29 and 30;
wherein said primer set for detecting E. chaffeensis comprises at least one of
(c)(i) SEQ ID NOs: 73 and 74 and (c)(ii) SEQ ID NOs: 33 and 34; and
wherein said primer set for detecting A. phagocytophilum comprises at least one of
(d)(i) SEQ ID NOs: 75 and 76 and (d)(ii) SEQ ID NOs: 25 and 26.
19 . The kit of claim 18 , wherein when said sample is obtained from a canine, said amplification control plasmid comprises SEQ ID NO: 45, and said kit further comprises canine specific primer set of SEQ ID NOs: 42 and 43.
20 . A method for detecting at least one tick-borne pathogen in a sample from an animal comprising
a) optionally, isolating DNA from said sample to provided isolated DNA; b) contacting said isolated DNA with a plurality of primer sets and DNA polymerase to provide a first layer PCR mix, wherein said plurality of primer sets detect at least one tick-borne pathogen; c) performing PCR on said first layer PCR mix to generate at least one amplicon; and d) determining the identify of said generated at least one amplicon, wherein said at least one amplicon is specific for detecting said at least one tick-borne pathogen in said sample.
21 . The method of claim 20 , wherein said animal from which said sample is obtained is a tick or a mammal.
22 . The method of claim 20 , wherein said at least one tick-borne pathogen is a Borrelia spp., Rickettsia -like bacteria, or a Babesia spp.; wherein said primer sets for detecting said Borrelia spp. is at least one of said primer sets of:
(i) SEQ ID NOs: 1 and 2, (ii) SEQ ID NOs: 5 and 7, (iii) SEQ ID NOs: 6 and 7, (iv) SEQ ID NOs: 11 and 13, (v) SEQ ID NOs: 12 and 13, and (vi) SEQ ID NOs: 17 and 18;
wherein said primer sets for detecting said Rickettsia -like bacteria is at least one of said primer sets of:
(vii) SEQ ID NOs: 21 and 22,
(viii) SEQ ID NOs: 25 and 26,
(ix) SEQ ID NOs: 29 and 30,
(x) SEQ ID NOs: 33 and 34, and
(xi) SEQ ID NOs: 36 and 34;
and wherein said primer set for detecting said Borrelia spp. is at least one of the primer sets of:
(xii) SEQ ID NOs: 38 and 39, and
(xiii) SEQ ID NOs: 77 and 39.
23 . The method of claim 22 , wherein said Borrelia spp. is selected from the group consisting of Borrelia burgdorferi, B. hermsii, B. turicatae , and B. parkeri ; wherein said Rickettsia -like bacteria is selected from the group consisting of Ehrlichia canis, E. chaffeensis, E. ewingii, Anaplasma phagocytophilum , and Rickettsia rickettsii ; and wherein said Babesia spp. is selected from the group consisting of Babesia canis vogeli, B. gibsoni, B. canis canis, B. canis rossi, B. caballi, B. odocoilei, B. divergens , and B. bigemina.
24 . The method of claim 22 , wherein said first layer PCR mix further comprises at least one probe to detect Borrelia spp., at least one probe to detect Rickettsia -like bacteria probe, and at least one probe to detect Babesia spp.; wherein said at least one Borrelia spp. probe comprises at least one of SEQ ID NOs: 3, 8, 14, and 19; wherein said at least one Rickettsia -like bacteria probe comprises at least one of SEQ ID NOs: 23, 27, and 31; and wherein said at least Babesia spp. probe comprises SEQ ID NO: 40.
25 . The method of claim 22 , wherein said tick-borne pathogen is Borrelia spp., said method further comprises
e) contacting said isolated DNA with at least one Borrelia spp. primer sets and DNA polymerase to provide a second layer PCR mix; f) performing PCR on said second layer PCR mix to generate at least one amplicon; and g) determining the identify of said generated at least one amplicon, wherein said at least one Borrelia spp. primer sets detect B. burgdorferi, B. hermsii, B. turicatae , or B. parkeri wherein said B. burgdorferi primer set is (i) SEQ ID NOs: 1 and 2; wherein said B. hermsii set is at least one of (ii) SEQ ID NOs: 5 and 7, (iii) SEQ ID NOs: 6 and 7, (xiv) SEQ ID NOs: 46 and 47, and (xv) SEQ ID NOs: 49 and 50; wherein said B. turicatae is at least one of (iv) SEQ ID NOs: 11 and 13 and (v) SEQ ID NOs: 12 and 13; and wherein said B. parkeri primer set is (vi) SEQ ID NOs: 17 and 18.
26 . The method of claim 25 , wherein said second layer PCR mix further comprises at least one probe to detect B. burgdorferi, B. hermsii, B. turicatae , or B. parkeri ; wherein said B. burgdorferi probe comprises SEQ ID NO: 3; wherein said B. hermsii probe comprises SEQ ID NO: 8; wherein said B. turicatae probe comprises SEQ ID NO: 14; and wherein said B. parkeri probe comprises SEQ ID NO: 19.
27 . The method of claim 22 , wherein said tick-borne pathogen is Rickettsia -like bacteria, said method further comprises
e) contacting said isolated DNA with at least one Rickettsia -like bacteria primer sets and DNA polymerase to provide a second layer PCR mix; f) performing PCR on said second layer PCR mix to generate at least one amplicon; and g) determining the identify of said generated at least one amplicon; wherein said at least one Rickettsia -like bacteria primer sets detect Rickettsia rickettsii, Anaplasma phagocytophilum, Ehrlichia canis, E. chaffeensis , or E. ewingii; wherein said R. rickettsii primer set is (vii) SEQ ID NOs: 21 and 22; wherein said A. phagocytophilum primer set is (viii) SEQ ID NOs: 25 and 26; wherein said E. canis primer set is (ix) SEQ ID NOs: 29 and 30; wherein said E. chaffeensis primer set is (x) SEQ ID NOs: 33 and 34; and wherein said E. ewingii primer set is (xi) SEQ ID NOs: 36 and 34.
28 . The method of claim 27 , wherein said second layer PCR mix further comprises at least one probe to detect R. rickettsii, A. phagocytophilum, E. canis, E. chaffeensis , or E. ewingii ; wherein said R. rickettsii probe comprises SEQ ID NO: 23; wherein said A. phagocytophilum probe comprises SEQ ID NO: 27; and wherein said E. canis probe, E. chaffeensis , and E. ewingii comprise SEQ ID NO: 31.
29 . The method of claim 22 , wherein said tick-borne pathogen is Babesia spp., said method further comprises
e) contacting said isolated DNA with at least one Babesia primer sets and DNA polymerase to provide a second layer PCR mix; f) performing PCR on said second layer PCR mix to generate at least one amplicon; and g) determining the identify of said generated at least one amplicon, wherein said at least one Babesia primer sets detect Babesia canis vogeli, B. gibsoni , or B. conradae; wherein said B. canis vogeli primer set is at least one of (xvi) SEQ ID NOs: 52 and 53 and (xvii) SEQ ID NOs: 56 and 57; wherein said B. gibsoni primer set is (xviii) SEQ ID NOs: 60 and 61; and wherein said B. conradae primer set is (xix) SEQ ID NOs: 64 and 65.
30 . The method of claim 29 , wherein said second layer PCR mix further comprises at least one probe to detect B. canis vogeli, B. gibsoni , or B. conradae ; wherein said B. canis vogeli probe comprises at least one of SEQ ID NO: 54 and SEQ ID NO: 58; wherein said B. gibsoni probe comprises SEQ ID NO: 62; and wherein said B. conradae probe comprises SEQ ID NO: 66.
31 . The method of claim 20 , wherein said at least one tick-borne pathogen is selected from the group consisting of B. burgdorferi, E. canis, E. chaffeensis , and A. phagocytophilum ; wherein said plurality of primer sets comprise a B. burgdorferi primer set, an E. canis primer set, an E. chaffeensis primer set, and an A. phagocytophilum primer set;
wherein said B. burgdorferi primer set comprises SEQ ID NOs: 69 and 70 or SEQ ID NOs: 1 and 2; wherein said E. canis primer set comprises SEQ ID NOs: 71 and 72 or SEQ ID NOs: 29 and 30; wherein E. chaffeensis primer set comprises SEQ ID NOs: 73 and 74 or SEQ ID NOs: 33 and 34; and wherein said A. phagocytophilum primer set comprises SEQ ID NOs: 75 and 76 or SEQ ID NOs: 25 and 26.
32 . The method of claim 31 , wherein said step (d) determining the identify of said generated at least one amplicon comprising running said amplicon on a gel and determining the size of said amplicon; wherein when said amplicon is 235 bp or 75 bp, B. burgdorferi is present in said sample; wherein when said amplicon is 389 bp or 113 bp, E. canis is present in said sample; wherein when said amplicon is 390 bp or 111 bp, E. chaffeensis is present in said sample; and wherein when said amplicon is 644 bp or 95 bp, A. phagocytophilum is present in said sample.
33 . A plasmid comprising SEQ ID NO: 68.Join the waitlist — get patent alerts
Track US2019093149A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.